Oral Sulfate Solution Is as Effective as Polyethylene Glycol with Ascorbic Acid in a Split Method for Bowel Preparation in Patients with Inactive Ulcerative Colitis: A Randomized, Multicenter, and Single-Blind Clinical Trial

Background/Aims Low-volume preparations for colonoscopy are gaining attention for their higher acceptability. However, the efficacy and safety of oral sulfate solution (OSS) preparations in patients with ulcerative colitis (UC) has not been well known. Therefore, we aimed to compare OSS and 2-L polyethylene glycol with ascorbic acid (PEG+Asc) for bowel preparation in inactive UC. Methods A multicenter, randomized, single-blind study was conducted at six tertiary referral hospitals in Korea. Outpatients with UC who had stable disease activity were randomly allocated to the OSS group or the 2-L PEG+Asc group for bowel preparation before colonoscopy. The study outcomes included treatment efficacy, safety, tolerability, and acceptability. Bowel cleansing was assessed using the Boston Bowel Preparation Scale and rated as successful cleansing if the score was ≥6. Patient acceptance and tolerability were assessed using a 4-point ordinal scale. Additionally, disease activity and laboratory data before and after colonoscopy were evaluated to check for safety. Results The OSS and 2-L PEG+Asc groups included 92 and 93 participants, respectively. No significant between-group difference was noted in successful cleansing (OSS [96.7%] vs 2-L PEG+Asc [97.8%], p=0.64). Moreover, the safety, acceptance, and tolerability were not significantly different (all p>0.05). Furthermore, no significant changes were found in serum electrolytes or disease activity in either group. Conclusions OSS is effective for colonoscopy cleansing, has acceptable tolerability, and does not affect disease activity; thus, it can be used safely for bowel preparation in patients with inactive UC.

[1]  A. Farioli,et al.  Determinants of symptom burden related to bowel preparation for colonoscopy. , 2022, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[2]  Myung-Gyu Choi,et al.  Comparison Between an Oral Sulfate Solution and a 2 L of Polyethylene Glycol/Ascorbic Acid as a Split Dose Bowel Preparation for Colonoscopy , 2019, Journal of clinical gastroenterology.

[3]  J. Feuerstein,et al.  Colorectal cancer surveillance in inflammatory bowel disease: Practice guidelines and recent developments , 2019, World journal of gastroenterology.

[4]  Y. Joo,et al.  Clinical comparison of low-volume agents (oral sulfate solution and sodium picosulfate with magnesium citrate) for bowel preparation: the EASE study , 2019, Intestinal research.

[5]  M. Kwak,et al.  Safety and Efficacy of Low-Volume Preparation in the Elderly: Oral Sulfate Solution on the Day before and Split-Dose Regimens (SEE SAFE) Study , 2019, Gut and liver.

[6]  Kyeong Ok Kim,et al.  Comparison of 4-L Polyethylene Glycol and 2-L Polyethylene Glycol Plus Ascorbic Acid in Patients with Inactive Ulcerative Colitis , 2017, Digestive Diseases and Sciences.

[7]  M. J. Nam,et al.  Comparative Evaluation of the Efficacy of Polyethylene Glycol With Ascorbic Acid and an Oral Sulfate Solution in a Split Method for Bowel Preparation: A Randomized, Multicenter Phase III Clinical Trial , 2017, Diseases of the colon and rectum.

[8]  D. Park,et al.  Randomized trial comparing oral sulfate solution with 4‐L polyethylene glycol administered in a split dose as preparation for colonoscopy , 2017, Journal of gastroenterology and hepatology.

[9]  G. Spinzi,et al.  2-Litre polyethylene glycol-citrate-simethicone plus bisacodyl versus 4-litre polyethylene glycol as preparation for colonoscopy in chronic constipation. , 2015, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[10]  C. Hassan,et al.  Colon Cleansing for Colonoscopy in Patients with Ulcerative Colitis: Efficacy and Acceptability of a 2-L PEG Plus Bisacodyl Versus 4-L PEG , 2015, Inflammatory bowel diseases.

[11]  D. Rex,et al.  A comparison of oral sulfate solution with sodium picosulfate: magnesium citrate in split doses as bowel preparation for colonoscopy. , 2014, Gastrointestinal endoscopy.

[12]  A. Barkun,et al.  Optimizing adequacy of bowel cleansing for colonoscopy: recommendations from the U.S. multi-society task force on colorectal cancer. , 2014, Gastrointestinal endoscopy.

[13]  Weilin Wang,et al.  A Meta-Analysis of Randomized Controlled Trials of Low-Volume Polyethylene Glycol plus Ascorbic Acid versus Standard-Volume Polyethylene Glycol Solution as Bowel Preparations for Colonoscopy , 2014, PloS one.

[14]  P. Rutgeerts,et al.  Anxiety is associated with impaired tolerance of colonoscopy preparation in inflammatory bowel disease and controls. , 2013, Journal of Crohn's & colitis.

[15]  P. Banks,et al.  Factors that Affect Adherence to Surveillance Colonoscopy in Patients with Inflammatory Bowel Disease , 2013, Inflammatory bowel diseases.

[16]  P. Collins Strategies for Detecting Colon Cancer and Dysplasia in Patients with Inflammatory Bowel Disease , 2013, Inflammatory bowel diseases.

[17]  C. Hassan,et al.  Randomised clinical trial: low‐volume bowel preparation for colonoscopy ‐ a comparison between two different PEG‐based formulations , 2012, Alimentary pharmacology & therapeutics.

[18]  L. Peyrin-Biroulet,et al.  Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[19]  J. Cubiella,et al.  Clinical practice Guidelines: quality of colonoscopy in colorectal cancer screening , 2012, Endoscopy.

[20]  I. Lawrance,et al.  Bowel cleansing for colonoscopy: prospective randomized assessment of efficacy and of induced mucosal abnormality with three preparation agents. , 2011, Endoscopy.

[21]  D. Rex,et al.  A randomized clinical study comparing reduced-volume oral sulfate solution with standard 4-liter sulfate-free electrolyte lavage solution as preparation for colonoscopy. , 2010, Gastrointestinal endoscopy.

[22]  J. D. Palma,et al.  A Randomized Clinical Study Evaluating the Safety and Efficacy of a New, Reduced-Volume, Oral Sulfate Colon-Cleansing Preparation for Colonoscopy , 2009, The American Journal of Gastroenterology.

[23]  Peter Higgins,et al.  Does colonoscopy cause increased ulcerative colitis symptoms? , 2007, Inflammatory bowel diseases.

[24]  A. Barkun,et al.  Commonly used preparations for colonoscopy: efficacy, tolerability, and safety--a Canadian Association of Gastroenterology position paper. , 2006, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[25]  D. Faigel,et al.  ASGE guideline: endoscopy in the diagnosis and treatment of inflammatory bowel disease. , 2006, Gastrointestinal endoscopy.

[26]  F. Farrokhyar,et al.  Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: Prevalence and impact on health , 2006, Inflammatory bowel diseases.

[27]  W. Tremaine,et al.  Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. , 1987, The New England journal of medicine.

[28]  M. Denters Fecal immunochemical test based colorectal cancer screening , 2013 .